Nucleoside-modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens. Jitthamstaporn S, Inthong R, Audomsun D, Chanasit S, et al. Allergy 2022 Sep 22. doi: 10.1111/all.15527.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jitthamstaporn S, Inthong R, Audomsun D, Chanasit S, et al. Nucleoside-modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens. Allergy 2022 Sep 22. doi: 10.1111/all.15527.
PMID: 36136090